Exercise Increases Insulin Sensitivity and Skeletal Muscle AMPK Expression in Systemic Lupus Erythematosus: A Randomized Controlled Trial

Fabiana B Benatti, Cíntia N H Miyake, Wagner S Dantas, Vanessa O Zambelli, Samuel K Shinjo, Rosa M R Pereira, Maria Elizabeth R Silva, Ana Lúcia Sá-Pinto, Eduardo Borba, Eloisa Bonfá, Bruno Gualano, Fabiana B Benatti, Cíntia N H Miyake, Wagner S Dantas, Vanessa O Zambelli, Samuel K Shinjo, Rosa M R Pereira, Maria Elizabeth R Silva, Ana Lúcia Sá-Pinto, Eduardo Borba, Eloisa Bonfá, Bruno Gualano

Abstract

Systemic lupus erythematosus (SLE) patients may show increased insulin resistance (IR) when compared with their healthy peers. Exercise training has been shown to improve insulin sensitivity in other insulin-resistant populations, but it has never been tested in SLE. Therefore, the aim of the present study was to assess the efficacy of a moderate-intensity exercise training program on insulin sensitivity and potential underlying mechanisms in SLE patients with mild/inactive disease. A 12-week, randomized controlled trial was conducted. Nineteen SLE patients were randomly assigned into two groups: trained (SLE-TR, n = 9) and non-trained (SLE-NT, n = 10). Before and after 12 weeks of the exercise training program, patients underwent a meal test (MT), from which surrogates of insulin sensitivity and beta-cell function were determined. Muscle biopsies were performed after the MT for the assessment of total and membrane GLUT4 and proteins related to insulin signaling [Akt and AMP-activated protein kinase (AMPK)]. SLE-TR showed, when compared with SLE-NT, significant decreases in fasting insulin [-39 vs. +14%, p = 0.009, effect size (ES) = -1.0] and in the insulin response to MT (-23 vs. +21%, p = 0.007, ES = -1.1), homeostasis model assessment IR (-30 vs. +15%, p = 0.005, ES = -1.1), a tendency toward decreased proinsulin response to MT (-19 vs. +6%, p = 0.07, ES = -0.9) and increased glucagon response to MT (+3 vs. -3%, p = 0.09, ES = 0.6), and significant increases in the Matsuda index (+66 vs. -31%, p = 0.004, ES = 0.9) and fasting glucagon (+4 vs. -8%, p = 0.03, ES = 0.7). No significant differences between SLT-TR and SLT-NT were observed in fasting glucose, glucose response to MT, and insulinogenic index (all p > 0.05). SLE-TR showed a significant increase in AMPK Thr 172 phosphorylation when compared to SLE-NT (+73 vs. -12%, p = 0.014, ES = 1.3), whereas no significant differences between groups were observed in Akt Ser 473 phosphorylation, total and membrane GLUT4 expression, and GLUT4 translocation (all p > 0.05). In conclusion, a 12-week moderate-intensity aerobic exercise training program improved insulin sensitivity in SLE patients with mild/inactive disease. This effect appears to be partially mediated by the increased insulin-stimulated skeletal muscle AMPK phosphorylation.

Clinical trial registration: www.ClinicalTrials.gov, identifier NCT01515163.

Keywords: GLUT4; aerobic exercise; glucagon; inflammatory rheumatic disease; insulin resistance.

Figures

Figure 1
Figure 1
Flow diagram of patients.
Figure 2
Figure 2
Insulin sensitivity and beta-cell function estimates in SLE-TR and SLE-NT (Pre and Post data and delta changes). Data are expressed as mean ± SD. SLE, systemic lupus erythematosus; SLE-TR, trained group (open circles); SLE-NT, non-trained group (black squares); AUC, area under the curve calculated from the response to the meal test. Mixed model tests adjusted by Pre values were used to assess possible differences in delta changes between groups. *p < 0.05, SLE-TR vs. SLE-NT; #p < 0.09, SLE-TR vs. SLE-NT.
Figure 3
Figure 3
Delta changes for protein expression of skeletal muscle phosphorylated AKT Ser 273, phosphorylated AMP-activated protein kinase (AMPK) Thr 172, total GLUT4, membrane GLUT4, and GLUT4 translocation in response to a meal test in SLE-TR and SLE-NT. SLE, systemic lupus erythematosus; SLE-TR, trained group (n = 4); SLE-NT, non-trained group (n = 5). Mixed model tests adjusted by Pre values were used to assess possible differences in delta changes between groups. *p < 0.05, SLE-TR vs. SLE-NT.

References

    1. Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab (2008) 294(1):E15–26.10.1152/ajpendo.00645.2007
    1. Yang G, Li C, Gong Y, Fang F, Tian H, Li J, et al. Assessment of insulin resistance in subjects with normal glucose tolerance, hyperinsulinemia with normal blood glucose tolerance, impaired glucose tolerance, and newly diagnosed type 2 diabetes (prediabetes insulin resistance research). J Diabetes Res (2016) 2016:9270768.10.1155/2016/9270768
    1. Miyake CNH, Gualano B, Dantas WS, Pereira RT, Neves W, Zambelli VO, et al. Increased insulin resistance and glucagon levels in mild/inactive systemic lupus erythematosus patients despite normal glucose tolerance. Arthritis Care Res (Hoboken) (2018) 70(1):114–24.10.1002/acr.23237
    1. Kahn SE. Clinical review 135: the importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab (2001) 86(9):4047–58.10.1210/jcem.86.9.7713
    1. Baron AD, Schaeffer L, Shragg P, Kolterman OG. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics. Diabetes (1987) 36(3):274–83.10.2337/diabetes.36.3.274
    1. Reaven GM, Chen YD, Golay A, Swislocki AL, Jaspan JB. Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1987) 64(1):106–10.10.1210/jcem-64-1-106
    1. Ferrannini E, Muscelli E, Natali A, Gabriel R, Mitrakou A, Flyvbjerg A, et al. Association of fasting glucagon and proinsulin concentrations with insulin resistance. Diabetologia (2007) 50(11):2342–7.10.1007/s00125-007-0806-x
    1. Ferrannini E, Natali A, Muscelli E, Nilsson PM, Golay A, Laakso M, et al. Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study. Diabetologia (2011) 54(6):1507–16.10.1007/s00125-011-2112-x
    1. Bird SR, Hawley JA. Update on the effects of physical activity on insulin sensitivity in humans. BMJ Open Sport Exerc Med (2016) 2(1):e000143.10.1136/bmjsem-2016-000143
    1. Sylow L, Kleinert M, Richter EA, Jensen TE. Exercise-stimulated glucose uptake – regulation and implications for glycaemic control. Nat Rev Endocrinol (2017) 13(3):133–48.10.1038/nrendo.2016.162
    1. Mikines KJ, Sonne B, Farrell PA, Tronier B, Galbo H. Effect of physical exercise on sensitivity and responsiveness to insulin in humans. Am J Physiol (1988) 254(3 Pt 1):E248–59.10.1152/ajpendo.1988.254.3.E248
    1. Frosig C, Rose AJ, Treebak JT, Kiens B, Richter EA, Wojtaszewski JF. Effects of endurance exercise training on insulin signaling in human skeletal muscle: interactions at the level of phosphatidylinositol 3-kinase, Akt, and AS160. Diabetes (2007) 56(8):2093–102.10.2337/db06-1698
    1. Ramsey-Goldman R, Schilling EM, Dunlop D, Langman C, Greenland P, Thomas RJ, et al. A pilot study on the effects of exercise in patients with systemic lupus erythematosus. Arthritis Care Res (2000) 13(5):262–9.10.1002/1529-0131(200010)13:5<262::AID-ANR4>;2-8
    1. Carvalho MR, Sato EI, Tebexreni AS, Heidecher RT, Schenkman S, Neto TL. Effects of supervised cardiovascular training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosus. Arthritis Rheum (2005) 53(6):838–44.10.1002/art.21605
    1. Miossi R, Benatti FB, Luciade de Sa Pinto A, Lima FR, Borba EF, Prado DM, et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care Res (Hoboken) (2012) 64(8):1159–66.10.1002/acr.21678
    1. dos Reis-Neto ET, da Silva AE, Monteiro CM, de Camargo LM, Sato EI. Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology (Oxford) (2013) 52(12):2187–95.10.1093/rheumatology/ket283
    1. Prado DM, Benatti FB, de Sa-Pinto AL, Hayashi AP, Gualano B, Pereira RM, et al. Exercise training in childhood-onset systemic lupus erythematosus: a controlled randomized trial. Arthritis Res Ther (2013) 15(2):R46.10.1186/ar4205
    1. Benatti FB, Miossi R, Passareli M, Nakandakare ER, Perandini L, Lima FR, et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatol Int (2015) 35(1):61–9.10.1007/s00296-014-3081-4
    1. Sabry A, Sheashaa H, El-Husseini A, Mahmoud K, Eldahshan KF, George SK, et al. Proinflammatory cytokines (TNF-alpha and IL-6) in Egyptian patients with SLE: its correlation with disease activity. Cytokine (2006) 35(3–4):148–53.10.1016/j.cyto.2006.07.023
    1. Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath JR, Pedersen BK. Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes (2005) 54(10):2939–45.10.2337/diabetes.54.10.2939
    1. Perandini LA, Sales-de-Oliveira D, Mello SB, Camara NO, Benatti FB, Lima FR, et al. Exercise training can attenuate the inflammatory milieu in women with systemic lupus erythematosus. J Appl Physiol (1985) (2014) 117(6):639–47.10.1152/japplphysiol.00486.2014
    1. Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1997) 40(9):1725.10.1002/art.1780400928
    1. Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol (2002) 29(2):288–91.
    1. Pinto AJ, Miyake CN, Benatti FB, Silva CA, Sallum AM, Borba E, et al. Reduced aerobic capacity and quality of life in physically inactive patients with systemic lupus erythematosus with mild or inactive disease. Arthritis Care Res (Hoboken) (2016) 68(12):1780–6.10.1002/acr.22905
    1. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care (1999) 22(9):1462–70.10.2337/diacare.22.9.1462
    1. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 28(7):412–9.10.1007/BF00280883
    1. Tura A, Kautzky-Willer A, Pacini G. Insulinogenic indices from insulin and C-peptide: comparison of beta-cell function from OGTT and IVGTT. Diabetes Res Clin Pract (2006) 72(3):298–301.10.1016/j.diabres.2005.10.005
    1. Dantas WS, Marcondes JA, Shinjo SK, Perandini LA, Zambelli VO, Neves WD, et al. GLUT4 translocation is not impaired after acute exercise in skeletal muscle of women with obesity and polycystic ovary syndrome. Obesity (Silver Spring) (2015) 23(11):2207–15.10.1002/oby.21217
    1. Gualano B, de Salles Painneli V, Roschel H, Artioli GG, Neves M, Jr, De Sa Pinto AL, et al. Creatine in type 2 diabetes: a randomized, double-blind, placebo-controlled trial. Med Sci Sports Exerc (2011) 43(5):770–8.10.1249/MSS.0b013e3181fcee7d
    1. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, USA: Lawrence Erlbaum Associates; (1998).
    1. Victora CG, Habicht JP, Bryce J. Evidence-based public health: moving beyond randomized trials. Am J Public Health (2004) 94(3):400–5.10.2105/AJPH.94.3.400
    1. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ (1999) 319(7211):670–4.10.1136/bmj.319.7211.670
    1. Fergusson D, Aaron SD, Guyatt G, Hebert P. Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis. BMJ (2002) 325(7365):652–4.10.1136/bmj.325.7365.652
    1. Baron AD. Insulin resistance and vascular function. J Diabetes Complications (2002) 16(1):92–102.10.1016/S1056-8727(01)00209-4
    1. Chakrabarti P, Kim JY, Singh M, Shin YK, Kim J, Kumbrink J, et al. Insulin inhibits lipolysis in adipocytes via the evolutionarily conserved mTORC1-Egr1-ATGL-mediated pathway. Mol Cell Biol (2013) 33(18):3659–66.10.1128/MCB.01584-12
    1. Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, et al. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the diabetes prevention program randomized trial. Ann Intern Med (2005) 142(8):611–9.10.7326/0003-4819-142-8-200504190-00009
    1. Due A, Larsen TM, Hermansen K, Stender S, Holst JJ, Toubro S, et al. Comparison of the effects on insulin resistance and glucose tolerance of 6-mo high-monounsaturated-fat, low-fat, and control diets. Am J Clin Nutr (2008) 87(4):855–62.10.1093/ajcn/87.4.855
    1. Due A, Larsen TM, Mu H, Hermansen K, Stender S, Astrup A. Comparison of 3 ad libitum diets for weight-loss maintenance, risk of cardiovascular disease, and diabetes: a 6-mo randomized, controlled trial. Am J Clin Nutr (2008) 88(5):1232–41.10.3945/ajcn.2007.25695
    1. Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol (2012) 13(4):251–62.10.1038/nrm3311
    1. Ellingsgaard H, Hauselmann I, Schuler B, Habib AM, Baggio LL, Meier DT, et al. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med (2011) 17(11):1481–9.10.1038/nm.2513
    1. Tench CM, McCarthy J, McCurdie I, White PD, D’Cruz DP. Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. Rheumatology (Oxford) (2003) 42(9):1050–4.10.1093/rheumatology/keg289
    1. McDonough AK, Curtis JR, Saag KG. The epidemiology of glucocorticoid-associated adverse events. Curr Opin Rheumatol (2008) 20(2):131–7.10.1097/BOR.0b013e3282f51031
    1. Chen YM, Lin CH, Lan TH, Chen HH, Chang SN, Chen YH, et al. Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study. Rheumatology (Oxford) (2015) 54(7):1244–9.10.1093/rheumatology/keu451

Source: PubMed

3
Tilaa